Outcome of Induction and Postremission Therapy in Younger Adults With Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study Ninety patients were randomly assigned. Toxicity ...

A dose-finding study was undertaken to determine the maximum-tolerated dose, and the recommended dose of docetaxel in combination with 12-h timed (22:00–10:00) flat infusion of 5-fluorouracil (5-FU) ...

The aim of this study was to determine the maximum tolerated dose of a fixed dose of docetaxel when combined with continuous infusion ifosfamide, with and without G-CSF support, in the treatment of ...

Docetaxel is a chemotherapy drug that is used to treat several forms of cancer. On March 22nd 2006, the United States Food and Drug Administration (FDA) approved the use of docetaxel in combination ...

The U.S. Food and Drug Administration (FDA) has made a safety announcement regarding the chemotherapy drug docetaxel. The agency says that people may feel intoxicated during or after treatment with ...

Dec. 4, 2003 (San Antonio) — Docetaxel (Taxotere) produced better overall survival and longer time to progression than paclitaxel (Taxol) in a randomized head-to-head trial of the two taxanes widely ...

The commonly used intravenous chemotherapy docetaxel "may cause patients to experience intoxication or feel drunk during and after treatment," warns the US Food and Drug Administration (FDA).

The US FDA has warned that intravenous administration docetaxal formulations contain alcohol and may cause intoxication among patients. A product label revision is being made. The U.S. Food and Drug ...

Docetaxel is a chemotherapy drug that is used to treat several forms of cancer including head and neck cancer. In October 2006, the United States Food and Drugs Administration (US FDA) approved the ...

The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis Pharma S.A. of its decision to withdraw its application for an extension of indication for the centrally authorised ...